Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (13017)	8/11/1998 12:45:00 AM
From: AlienTech	Read Replies (1) \| Respond to of 23519

Big K has already stated that he does not invest in companies like VVUS. But CEPH is looking much better than VVUS at these levels.

To: VLAD who wrote (13017)	8/11/1998 12:52:00 AM
From: Mkilloran	Respond to of 23519

vlad...I'am not expecting Bigkny3 to buy any Vivus..dosen't fit his profile of investment...but he does recognize that there is room for two companies...Viiagra will be the number one pick...Vivus will get the Nitrate users and more severe cases and some saftey minded consumers that rather not risk Viagra... Muse is a niche product...but 10% of a $4 billion world wide ED marketplace for a small lean company...which vivus has become this month...will generate large profits on sales in 1999. With 100% expansion in yr2000 with the new plant in Ireland... With Alibra they should get a few more customers than with Muse...less side effects.